Oral News and Research

RSS
India is poised to revolutionize biotechnology

India is poised to revolutionize biotechnology

FASgen awarded grant for refinement of its serum fatty acid synthase

FASgen awarded grant for refinement of its serum fatty acid synthase

Heart study observes 20th year in Forsyth County

Heart study observes 20th year in Forsyth County

Scientists decode genome of Streptococcus sanguinis

Scientists decode genome of Streptococcus sanguinis

Thyroid surgery can be done safely in an outpatient setting

Thyroid surgery can be done safely in an outpatient setting

Efficacy of Guanilib confirmed for inflammatory bowel disease

Efficacy of Guanilib confirmed for inflammatory bowel disease

Bayer Healthcare Pharmaceuticals launches in the U.S.

Bayer Healthcare Pharmaceuticals launches in the U.S.

Multiple myeloma trial has shows significant improvement in survival

Multiple myeloma trial has shows significant improvement in survival

No apparent increase in coronary heart disease for women who initiate hormone therapy

No apparent increase in coronary heart disease for women who initiate hormone therapy

A mild head injury can increase your chance of developing a sleep disorder

A mild head injury can increase your chance of developing a sleep disorder

Treatment options for endometriosis

Treatment options for endometriosis

Researchers document rare case of hepatitis B virus transmission

Researchers document rare case of hepatitis B virus transmission

Rabies vaccine approach against HIV shows promise

Rabies vaccine approach against HIV shows promise

About 50% of people fail to take medication as directed

About 50% of people fail to take medication as directed

HHS Inspector General Office to review conflicts of interest for NIH grantees, employees

HHS Inspector General Office to review conflicts of interest for NIH grantees, employees

Study results on bifeprunox in patients with schizophrenia

Study results on bifeprunox in patients with schizophrenia

Novel anti-oxidant and anti-inflammatory agent reduces coronary events

Novel anti-oxidant and anti-inflammatory agent reduces coronary events

FDA approves Ceprotin to treat severe congenital protein C deficiency

FDA approves Ceprotin to treat severe congenital protein C deficiency

New cardiovascular treatment approaches

New cardiovascular treatment approaches

Review of the health effects of Swedish Snus released

Review of the health effects of Swedish Snus released

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.